JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
Hosted on MSN
FDA approves J&J’s TECNIS PureSee intraocular lens
Johnson & Johnson (J&J) has received approval from the US Food and Drug Administration (FDA) for its TECNIS PureSee extended depth of focus (EDOF) intraocular lens (IOL), designed for use in cataract ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Johnson & Johnson (NYSE: JNJ) will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of ...
Johnson & Johnson has announced the introduction of its TECNIS PureSee purely refractive intraocular lens (IOL) for individuals with presbyopia in India. “The TECNIS PureSee IOL features a purely ...
Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results